Cargando…
Plasma mRNA as liquid biopsy predicts chemo-sensitivity in advanced gastric cancer patients
Predictive biomarkers based individualized chemotherapy can improve efficacy. However, for those advanced patients, it may be impossible to obtain the tissues from operation. Tissues from biopsy may not be always enough for gene detection. Thus, biomarker from blood could be a non-invasive and usefu...
Autores principales: | Shen, Jie, Kong, Weiwei, Wu, Yuanna, Ren, Haozhen, Wei, Jia, Yang, Yang, Yang, Yan, Yu, Lixia, Guan, Wenxian, Liu, Baorui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332895/ https://www.ncbi.nlm.nih.gov/pubmed/28261345 http://dx.doi.org/10.7150/jca.17369 |
Ejemplares similares
-
Plasma mRNA expression levels of BRCA1 and TS as potential predictive biomarkers for chemotherapy in gastric cancer
por: Shen, Jie, et al.
Publicado: (2014) -
The plasma levels of 12 cytokines and growth factors in patients with gastric cancer
por: Zou, Zhengyun, et al.
Publicado: (2018) -
A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer
por: Shen, Jie, et al.
Publicado: (2013) -
SULF2 Methylation Is Associated with In Vitro Cisplatin Sensitivity and Clinical Efficacy for Gastric Cancer Patients Treated with a Modified FOLFOX Regimen
por: Shen, Jie, et al.
Publicado: (2013) -
Application progress of liquid biopsy in gastric cancer
por: Ma, Xiaoting, et al.
Publicado: (2022)